# Indium phosphide quantum dots: advanced synthesis, surface engineering, and biomedical applications in imaging, sensing, and therapy

**Authors:** A. K. Kareem, Musallam Ahmed Salim Tabook, Esraa H. J. Mahdi, Ahmed Said Badawy, M. M. Rekha, Laxmidhar Maharana, P. Grace Kanmani Prince, Gaganjot Kaur, Hamza Fadhel Hamzah, Nadia Sarhan

PMC · DOI: 10.1039/d5ra06797a · 2026-02-26

## TL;DR

Indium phosphide quantum dots are promising non-toxic nanomaterials for biomedical imaging, sensing, and therapy due to their near-infrared properties and biocompatibility.

## Contribution

The paper introduces advanced synthesis and surface engineering methods that enhance the safety and performance of InP QDs for biomedical use.

## Key findings

- InP QDs exhibit low cytotoxicity and superior near-infrared emission for high-sensitivity bioimaging.
- Surface engineering techniques like ligand exchange and polymer coatings improve stability and reduce indium release.
- InP QDs enable applications in photodynamic therapy, drug delivery, and neural prosthetics.

## Abstract

Indium phosphide quantum dots (InP QDs) are emerging as non-toxic, tunable, and biocompatible semiconductor nanomaterials with transformative potential in biomedical applications. This review highlights cutting-edge synthesis methods, including nonclassical nucleation and scalable production, alongside innovative surface engineering techniques such as ligand exchange, polymer coatings, and inorganic passivation to overcome challenges like surface defects and indium release. We explore their superior near-infrared (NIR) emission and low cytotoxicity, enabling high-sensitivity NIR bioimaging, resonance energy transfer-based biosensing, photodynamic therapy, drug delivery, and neural prosthetics. Compared to other nanoparticles, InP QDs offer enhanced NIR performance and regulatory compliance, making them economically viable for diagnostics and therapeutics. By addressing safety concerns through advanced shell designs and safer precursors, InP QDs pave the way for clinical translation. This review, with a focused emphasis on the biomedical translation of InP QDs, provides a structured roadmap for researchers and clinicians to harness their potential in next-generation healthcare solutions.

This review summarizes advances in InP quantum dot synthesis and surface engineering, highlighting strategies that enable low-toxicity NIR imaging, biosensing, and phototherapeutic applications for biomedical translation.

## Full-text entities

- **Genes:** Havcr1 (hepatitis A virus cellular receptor 1) [NCBI Gene 171283] {aka KIM-1, TIM-1, Tim1, Timd1}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Ret (ret proto-oncogene) [NCBI Gene 19713] {aka PTC, RET51, RET9, c-Ret}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Casp9 (caspase 9) [NCBI Gene 12371] {aka APAF-3, CASP-9, Caspase-9, ICE-LAP6, Mch6}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Cldn4 (claudin 4) [NCBI Gene 12740] {aka Cep-r, Cpetr, Cpetr1}, Psca (prostate stem cell antigen) [NCBI Gene 72373] {aka 2210408B04Rik}, Afp (alpha fetoprotein) [NCBI Gene 11576], Cea (carcinoembryonic antigen gene family) [NCBI Gene 111518], Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Cish (cytokine inducible SH2-containing protein) [NCBI Gene 12700] {aka CIS-1, CIS1, Cis, F17, F23, SOCS}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** infection (MESH:D007239), cancer (MESH:D009369), spindle or chromosomal abnormalities (MESH:D002869), Toxicity (MESH:D064420), heavy (MESH:D008595), inflammation (MESH:D007249), abscesses (MESH:D000038), metal (MESH:D013651), epilepsy (MESH:D004827), platelet aggregation (MESH:D001791), Thrombus (MESH:D013927), metastasis (MESH:D009362), Parkinson's (MESH:D010300), pancreatic cancer (MESH:D010190), reproductive toxicity (MESH:D060737), acute (MESH:D000208), infectious and chronic diseases (MESH:D003141), bacterial (MESH:D001424), phototoxicity (MESH:D017484), HF (MESH:D011015), renal toxicity (MESH:D007674), hypoxic (MESH:D002534)
- **Chemicals:** LA (MESH:D008063), thiols (MESH:D013438), LTA (MESH:D017572), ZnCl2 (MESH:C016837), PEG (MESH:D011092), HF (MESH:D006858), CPP (MESH:D057846), Amine (MESH:D000588), carbon (MESH:D002244), polymer (MESH:D011108), InP (MESH:C090882), MC (MESH:C061001), AIP (-), Metal (MESH:D008670), superoxide (MESH:D013481), Al (MESH:D000535), OAm (MESH:C008703), 4-hydroxyphenylacetic acid (MESH:C008070), ZnSe (MESH:C044696), singlet oxygen (MESH:D026082), sulfur (MESH:D013455), gold (MESH:D006046), Silica (MESH:D012822), phosphorus (MESH:D010758), salt (MESH:D012492), Sulfide (MESH:D013440), Zn (MESH:D015032), oxygen (MESH:D010100), iron oxide (MESH:C000499), In (MESH:D007204), myristic acid (MESH:D019814), OA (MESH:D019301), PBS (MESH:D007854), Pen (MESH:D010396), Rhodamine 6G (MESH:C026188), ZnEt2 (MESH:C059490), caffeic acid (MESH:C040048), Zn-P (MESH:C010423), PH3 (MESH:C003800), Cu (MESH:D003300), gentamicin (MESH:D005839), HS (MESH:D006859), HCl (MESH:D006851), cellulose (MESH:D002482), Cd (MESH:D002104), Zn3P2 (MESH:C009701), ethanol (MESH:D000431), lead sulfide (MESH:C018391), methicillin (MESH:D008712), aminophosphine (MESH:C000629094), hydroxyl (MESH:D017665), oxide (MESH:D010087), ROS (MESH:D017382), quinine sulfate (MESH:D011803), chloride (MESH:D002712), EDC (MESH:C024565), H2SO4 (MESH:C033158), MSA (MESH:C046062), heavy-metal (MESH:D019216), neodymium (MESH:D009354)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Feline calicivirus (no rank) [taxon 11978], Human coronavirus 229E (no rank) [taxon 11137], Hydra vulgaris (swiftwater hydra, species) [taxon 6087], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Cell lines:** J774 — Mus musculus (Mouse), Mouse reticulum cell sarcoma, Cancer cell line (CVCL_4692), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), MiaPaCa — Homo sapiens (Human), Pancreatic undifferentiated carcinoma, Cancer cell line (CVCL_0428), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939315/full.md

---
Source: https://tomesphere.com/paper/PMC12939315